Mark Perazella, M.D., F.A.C.P.
Associate Professor of Medicine
Director, Clinical Fellowship Program Associate Director, Acute Hemodialysis

B.S., 1981: University of Connecticut
M.D., 1988: New York Medical College
Residency: St. Mary's Hospital
Fellowship: Yale University

E-mail: mark.perazella@yale.edu

As a clinician-educator, director of the Renal Fellowship Program in the Yale Section of Nephrology and member of the American Society of Nephrology Training Program Directors Executive Committee, one of my major objectives is to train and prepare fellows for a career in academic clinical nephrology. As such, the focus of education is in the areas of general consultative nephrology, intensive care nephrology (CVVHD) and chronic kidney disease and End Stage Renal Disease (ESRD) care. Important to this educational process is the incorporation of scholarly activity and clinical investigation into the training program. As part of this process, fellows are instructed on the basics of epidemiology and statistics, educated in the process of authorship, and engaged in meaningful clinical research. My own interests in academic clinical nephrology include the etiology and treatment of dialysis-associated hypotension, surveillance of vascular access, renal complications of therapeutic agents, disorders of potassium homeostasis and HIV-associated renal disease. I serve as associate editor for the American Journal of Kidney Diseases, Renal Pharmacology editor for Clinical Journal American Society of Nephrology and assistant editor for Seminars in Dialysis where I edit the educational series “Fellow's Forum in Dialysis”, which is a place where fellows can publish on ESRD topics under the guidance of a faculty mentor, and co-editor for “Images in Dialysis”. I also serve on the editorial board of the American Journal of Medicine, American Journal of Medical Sciences and Hospital Physician. At the hospital level, I serve as director of the Acute Dialysis program.

PubMed Search for articles by faculty member

References

Brewster UC, Coca SG, Reilly RF, Perazella MA: Effect of intravenous iron on hemodialysis catheter microbial colonization and blood-borne infection. Nephrology 10 (2): 124-128, 2005.

Rifkin BR, Brewster UC, Aruny JE, Perazella MA: Percutaneous Balloon Cryoplasty: A New Therapy for Intractable Venous Stenosis? Am J Kidney Dis 45 (2): E27-E32, 2005

Motiwala S, Brewster UC, Perazella MA, Peixoto AJ: Reliability of a non-invasive device to measure systemic
hemodynamics in hemodialysis patients. Blood Pressure Monitoring 11:33-36, 2006

Rifkin B, Perazella MA: Tenofovir-associate nephrotoxicity: Fanconi syndrome and acute renal failure. Am J Med 117:282-284, 2004

Coca SG, Perazella MA, Buller GK: The cardiovascular implications of hypokalemia. Am J Kidney Dis 45:233-247, 2005

Brewster UC, Perazella MA: The Renin-Angiotensin-Aldosterone System and the kidney: Effects on kidney disease. Am J Med 116:263-272, 2004

Markowitz G, Perazella MA: Drug-induced renal failure: Focus on tubulointerstitial disease. Clinica Chimica Acta 351:31-47, 2005

Perazella MA, Rastegar A: Disorders of potassium and acid-base metabolism in association with renal disease In: Schrier RW, ed. Diseases of the Kidney. 2006 8th Edition

Perazella MA, Parikh C: Pharmacology. Am J Kidney Dis 46:1129-1139, 2005

Perazella MA: Drug-induced nephropathy: an update. Expert Opinion in Drug Safety. 4(4):689-706, 2005

Leinau L, Perazella MA: Hip fractures in ESRD patients: Incidence, risk factors, and prevention. Sem Dialysis 19:75-79, 2006

Perazella MA, Khan S: Increased Mortality in Chronic Kidney Disease: A Call to Action. Am J Med Sci 331:150-153, 2006

Zhu X, Perazella MA: Non-hematologic complications of erythropoietin therapy. Seminars Dialysis 19:279-284, 2006